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Using a modified charcoal method, we could detect a steroid-binding component in rat lung cytosol which 
specifically binds R5020, progesterone, and some of its natural derivatives. The concentration of binding 
sites is high (30-40 pmol/mg protein), the affinity is moderate, the Kd of the R5020 complex being 
-lo-’ M. Proteolytic enzymes and sulfhydryl reagents destroyed the binding sites indicating the protein 
nature and the requirement for disulfide bonds. The protein sedimented in the 2 S range thus had an M, 
of 10 000-15 000. Further characteristics are the extreme heat (30 min at 1OO’C) and acid (pH 1) stability. 
These properties and the fact that it was not detected in serum, distinguish this binding protein from 
receptors and specific serum steroid binders. 
Rat Lung Cytosol 
1. INTRODUCTION 
The mechanism of steroid hormone action is 
dependent on a complex interaction of steroids 
with proteins such as enzymes, special receptor 
proteins [ 11, serum-binding proteins [2], and tissue 
specific-binding proteins, like the sterol carrier 
proteins in the liver [3]. The latter seem to be im- 
portant for a regular metabolic conversion of 
squalene to cholesterol. In addition to these 
steroid-binding proteins whose functions are 
relatively well understood, steroid-binding entities 
of which the physiological functions are not yet 
understood have been described [4-61. Here, we 
describe the first experiments, to characterise an 
unusual, soluble, mainly progesterone-binding 
protein in the adult rat lung. 
2. MATERIALS AND METHODS 
2.1. Materials 
The radioactive ligand [3H]R5020 (17,21-dime- 
thyl-19-norpregna-4,9-diene-3,20-dione), spec. act. 
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87 Ci/mmol, unlabelled R5020, and R1881 (17~,&- 
hydroxy-17a-methyl-4,9,11-estratriene-3-one) were 
purchased from NEN; ORG 2058 (16cu-ethyl-21- 
hydroxy-9-norpreg-4-ene-3,20-dione) was obtained 
from Amersham; diethylstilbestrol (DES) and 
cholesterol from Serva; all other steroids were pur- 
chased from Makor Chemicals. The enzymes 
papain (21 units/mg), and non-specific protease 
type 6 from Streptomyces griseus (5 units/mg) 
were purchased from Sigma; cr-chymotrypsin (45 
units/mg) from Serva; and protease V8 from 
Staphylococcusaureus(500 units/mg) was obtained 
from Miles Lab. 
2.2. Preparation of rat lung cytosols 
Lungs from male and female adult 
Sprague-Dawley rats were homogenized in 10 mM 
Tris-HCl, 1.5 mM EDTA buffer (pH 7.4) (TE- 
buffer) at 0°C using an Ultra-Turrax. After cen- 
trifugation at 105 000 x g the supernatant was 
treated with dextran-coated charcoal (DCC) for 30 
min at 4°C. The final concentration of charcoal 
was 0.5% and dextran 0.05%. DCC was removed 
from the cytosol by centrifugation at 2000 x g for 
15 min. With this procedure most of the unbound 
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and low affinity-bound steroids were removed. 
Cytosol which has been treated in this maner will 
be termed ‘O”-cytosol’ to distinguish it from 
X5”-cytosol’, which was prepared by heating the 
‘O”-cytosol’ for 2 h at 65°C and subsequent cen- 
trifugation for 30 min at 105 000 x g. 
2.3. Binding studies 
[3H]R5020, a synthetic ligand for the determina- 
tion of progesterone (prog.) receptors, was used 
because it has the highest affinity of all steroids 
tested for this binding component. The spec. act. 
of commercially available [3H]R5020 was decreas- 
ed to 4.35 Ci/mmol with unlabelled R5020. The in- 
cubation conditions for all subsequent binding 
measurements were, unless otherwise noted, as 
follows: 0.2 ml aliquots of cytosol were incubated 
with defined concentrations of steroids (see below) 
for 1 h at 4°C. Removal of the unbound steroid 
was achieved by adding 0.5 ml of a DCC suspen- 
sion (0.5% Norit A; 0.05O70 Dextran) and shaking 
for 2.5 min at 4°C followed by centrifugation at 
1500 x g for 5 min. Under these conditions about 
99% of the free steroid was removed with only 
minimal dissociation of the steroid-protein com- 
plex (fig. 1). 
2.3.1. Saturation analysis 
Cytosol was incubated with increasing amounts 
of [3H]R5020 (40-320 nM) alone, or in the 
presence of 32 PM unlabelled R5020. The upper 
limit of solubility for R5020 in cytosol was 4 x 
10m5 M. The values of specific binding were plotted 
as in [7], providing the equilibrium dissociation 
constant (&), and concentration of binding 
sites/mg protein. Protein was determined as in [8]. 
2.3.2. Time course of association 
To determine the minimum incubation time re- 
quired to reach equilibrium, cytosol was incubated 
with 160 nM [3H]R5020 f 16pM R5020, and after 
the appropriate time-intervals DCC was added. 
2.3.3. Time course of dissociation 
After incubation of 8 ml of cytosol with 160 nM 
[3H]R5020 for 1 h at 4”C, unlabelled R5020 or 
prog. was added to reach a final concentration of 
40 PM and incubated. Aliquots (0.2 ml) were 
removed at different time-intervals and treated 
with DCC as above. 
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2.3.4. Specificity studies 
Cytosol was incubated for 1 h with 320 nM 
[3H]R5020 alone, or together with unlabelled 
steroids in ratio of 1: 1, 1: 10 and 1: 100. In some 
cases only a IOO-fold excess of unlabelled steroids 
was used as competitor. 
2.4. Stability of the binding component towards 
heating, acid-alkali treatment, disulfide 
reducing reagents and proteolytic enzymes 
The measurement of binding activity after the 
following treatments was performed with 160 nM 
[3H]R5020 * 16 PM unlabelled R5020. 
2.4.1. Temperature stability 
‘65”-Cytosol’ was heated for different periods of 
time at 100°C and recentrifuged at 105 000 x g 
for 20 min. 
2.4.2. Exposure to extreme acidic or basic milieu 
‘0”~Cytosol’ and ‘65”~cytosol’ were adjusted to 
pH 1 and pH 12 with HCl and NaOH, respect., in- 
cubated for 1 h at 25°C and re-titrated to pH 7. 
2.4.3. Influence of S-S reducing reagents 
‘65”-Cytosol’ was treated with either 10 mM cy- 
monothioglycerol (wMTG), P-mercaptoethanol 
@‘-mere.) or dithiothreitol (DTT) for 10 min either 
at lOO”C, and then cooled on ice, or just kept on 
ice. 
2.4.4. Enzyme digestion 
‘65”-Cytosol’ was incubated with either papain 
(1 mg/ml) together with 10 mM EDTA and 10 mM 
cysteine [9] for 2 h at 37”C, or with cy- 
chymotrypsin (1 mg/ml), non-specific protease (1 
mg/ml) or protease V8 [lo] (0.5 mg/ml), both at 
37°C for 24 h. The cytosols were made in 50 mM 
with respect o Tris; the enzymes were dissolved in 
50 mM Tris-HCl (pH 7.4). 
2.5. Sucrose density gradient centrifugation 
Concentrated ‘65”-cytosol’ (2 ml) or ‘0”~cyto- 
sol’ (2 ml) were layered on top of a linear gradient 
of 2.5-17.5% sucrose and centrifuged for 20 h at 
300 000 x g at 4°C. Myoglobin was used as a 
marker protein. Two drop fractions from the gra- 
dient were diluted with 150 ~1 of TE buffer and 
incubated with 160 nM [3H]R5020 alone. In a 
parallel gradient, fractions were incubated with 
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160 nM [3H]R5020 + 16 PM unlabelled R5020. 
This post-labelling method was necessary because 
of the relatively rapid dissociation of the 
protein-steroid complex. 
3. RESULTS 
3.1. Establishing conditions for the binding assay 
A standardisation of the binding assay pro- 
cedure has been important for all subsequent ex- 
periments. Fig. 1 shows that specific binding did 
not decrease by more than -5% by DCC treatment 
for 2.5 min at 4°C. 
After 1 h the association of [3H]R5020 to the 
binding component reaches equilibrium (fig. 2). 
The dissociation of the steroid-protein complex in 
the presence of a 250-fold excess of R5020 or prog. 
occurred within 1 h. 
3.2. Determination of Kd and no. of binding sites 
In cytosol with cont. -2 mg protein/ml, satura- 
tion was achieved at -320 nM [3H]R5020 (fig. 3). 
Scatchard plot-analysis of the specific binding pro- 
vided a& of 1.33 x IO-’ M (6 x 10p8-2 x lo-‘) 
with no apparent differences between ‘O”-cytosol’ 
and ‘65”~cytosol’. The no. of binding sites was 
-30-40 pmol/mg protein in ‘O”-cytosol’, and 
SO-100 pmol/mg protein in ‘65”-cytosol’, the lat- 
ter value being due to loss of non-specific protein 
during heating procedure. 
Fig. 1. Dissociation of [3H]R5020 from its binding site 
in ‘O’cytosol in the presence of DCC: (0) total; (0) 
non-specific; (A) specific binding. 
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Fig. 2. Dissociation: Preincubated ‘65”-cytosol’ (160 nM 
[3H]R5020 at4°C for 1 h) was further incubated with 40 
pM ( n ) R502O or (A) prog. Association: Specific binding 
of [3H]R5020 in ‘65”~cytosol’ asa function of time. 
3.3 Specificity 
At least 3 determinations have been performed 
with each of the following cytosols: ‘0”~cytosol’ 
and ‘65”-cytosol’ from male and from female rat 
lung. No significant difference in the affinity of 
the different steroids for the [3H]R5020 binding 
entity was observed. Fig. 4 shows an example of 
the specificity studies with female ‘65”-cytosol’. 
The competition experiments revealed two surpris- 
ing facts: Concerning the natural steroids, prog. 
and its immediate derivatives (5,&pregnane-3,20- 
dione, 1 l-desoxycorticosterone-21-hydroxyproges- 
terone, 17cz-hydroxyprogesterone and to an equal 
extent 4-androstene-3,17-dione) are the most potent 
competitors. Neither the synthetic gestagen, ORG 
2058 (another ligand with high affinity to the prog. 
receptor) nor estrogens, androgens or glucocorti- 
349 
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Fig. 3. Saturation analysis of the [3H]R5020 binding in ‘65”-cytosol’ and Scatchard plot-analysis: (0) total; (0) non- 
specific and (A) specific binding. 
coids displayed significant affinity to the binding 
component. However, synthetic estrogens such as 
DES and 17a-ethinylestradiol showed competitive 
properties similar to prog. or S/3-pregnane-3,20- 
dione. 
3.4. Stability of the rat lung-binding component 
against heat, acid and alkali, S-S reducing 
reagents, and proteolytic enzymes 
Fig. 5 shows the time course of inactivation of 
binding at 100°C. After 4 h a complete loss of bin- 
ding activity could be observed. When ‘OO-cytosol’ 
and ‘65”-cytosol’ were exposed to extreme acidic 
or alkaline milieus, followed by re-titration to 
neutral pH, we recovered > 95% of binding activi- 
ty in the acid-treated cytosol, but none after ex- 
posure to alkali (not shown). The disulfide reduc- 
ing reagents cu-MTG, ,&merc. and DTT were very 
effective in reducing the binding activity when the 
cytosol was incubated at 100°C for 10 min (table 
l), but only DTT decreased the specific binding at 
0°C. The fact that neither (Y-MTG nor ,&merc. in- 
activated the binding activity at 0°C indicates that 
the loss of binding at 100°C was not a non-specific 
effect due to the alteration of the incubating milieu 
by the sulfhydryl reagents. We therefore conclude 
that disulfide bonds are essential for steroid bin- 
ding. Reduction of binding activity as a result of 
the use of different proteolytic enzymes to prove 
its protein nature is demonstrated in table 2. It has 
not yet been determined if the binding protein con- 
tains carbohydrates. 
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Fig. 4. Specificity of [3H]R5020 binding measured in 
‘65”-cytosol’: 0.2 ml of cytosol was incubated with 320 
nM [‘H]R5020 alone, or diluted with following unlabel- 
led steroids in ratios of 1: 1, 1: 10 and 1: 100: (0) 
R5020; (v) prog.; (m) DES; ( q ) S/3-preg- 
nane-3,20-dione; (A) R1881; (0) DOC; (v) 17a-hydro- 
xyprogesterone; (v) 4-androstene-3,17-dione and ( + ) 
17a-ethinylestradiol. Only a lOO-fold excess was applied 
for (0) estrone, estradiol, estriol, testosterone, Scu-dihy- 
drotestosterone, cortisol, corticosterone, dexametha- 
sone, triamcinolone and pregnenolone, and (A) 
cholesterol. 
3.5. Molecular property on sucrose density 
gradient (fig. 6) 
A first estimate of the M,-value of the binding 
protein was obtained from sucrose density gradient 
analysis (M 10 000-15 000). The binding entity 
displayed a sedimentation coefficient somewhat 
below myoglobin (2 S). Analysis of ‘O”-cytosol’ 
and ‘65’-cytosol’ showed identical results. 
Fig. 6. Post-labelling sucrose density gradient analysis of 
[3H]R5020 binding entity: (0) total; (0) non-specific 
and (A) specific [3H]R5020 binding; the arrow indicates 
the sedimentation property of myoglobin (2 S). 
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Fig. 5. Specific binding of [3H]R5020 after heating 
‘65”-cytosol’ for different periods of time at 100°C. 
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Table 1 
Influence of 3 different S-S reducing reagents on the 
binding activity for [3H]R5020 in ‘65”-cytosol’ 
Reagent Control 1 Control 2 Reagent Reagent 
(OOC) (1OOOC) (OOC) (1OO~C) 
(nM [3H]R5020 specifically bound) 
&Merc. 21.5 24.5 20.6 7.5 
DTT 22.6 23.7 8.2 8.2 
cu-MTG 23.8 24.2 23.1 8.2 
Before measuring the binding activity, cytosols were 
treated as follows: control 1, kept on ice; control 2, 
heated for 10 min and cooled on ice; reagent (O’C), kept 
on ice with reagent for 10 min; reagent (lOO’C), heated 
with reagent for 10 min and cooled on ice. Results 
represent he mean of 2 determinations 
Table 2 
Influence of 4 different proteolytic enzymes on the 
binding activity for [3H]R5020 in ‘65”-cytosol’ 
Enzyme Control Enzyme Inacti- 
incub. incub. vation 
(070) 
(nM [3H]R5020 
specifically bound) 
Papain (1 mg/ml) 53.7” 2.8 95 
cY-Chymotrypsin 
(1 mg/ml) 77.1 5.8 93 
Protease non-spec. 
(1 mg/ml) 76.5 0.0 100 
Protease V8 (0.5 mg/ml) 75.8 26.4 65 
aResults represent he mean of 2 determinations 
4. DISCUSSION 
The steroid binding protein described is 
characterized by extreme heat and acid stability, 
lability against mercaptanes, and by its relatively 
low M,. We could detect this type of 
[3H]R5020-binding in the rat lung only, but not in 
organs of this animal such as thymus, kidney, 
liver, heart or brain nor in serum. All these fin- 
dings clearly distinguish this binding entity from 
any classical steroid receptors which are 
characterized by high affinity (& 10-10-10-9 M) 
and specificity towards its correspondent steroid as 
well as by low capacity (< 2 pmol/mg protein). 
Its characteristics and the fact that we could not 
detect it in serum distinguish our binding protein 
from serum steroid binders. Also, its properties are 
different from the sterol-carrier proteins [ 11,121 
which have a relatively high affinity for cholesterol 
only, but not for prog. The biological function of 
this protein is not yet understood. Although its af- 
finity towards prog. is moderate, its binding 
capacity is about loo-times greater than for steroid 
receptors. In addition, it could not be excluded 
that the binding protein is accumulated in specific 
cell types of the lung or cell compartments uch as 
membranes, thus reaching high local concentra- 
tions necessary to exert biological effects despite 
the low physiological prog. levels and the low af- 
finity of the binding site. Thus it could serve to ac- 
cumulate prog. in the cell or to prevent its binding 
to the glucocorticoid receptor in the lung [ 131. The 
latter possibility may be important, because there 
are reports that prog. interacts with the 
glucocorticoid-receptor complex either by direct 
binding or by enhancing the dissociation of 
glucocorticoids from their receptors [ 14- 161. 
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